Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Eur J Pharm Biopharm ; 127: 371-377, 2018 Jun.
Article de Anglais | MEDLINE | ID: mdl-29499301

RÉSUMÉ

Despite extensive investigations, the clinical translation of nanocarrier-based drug delivery systems (NDDS) for cancer therapy is hindered by inefficient delivery and poor tumor penetration. Conventional chemotherapy by administration of free small molecule anticancer drugs remains the standard of care for many cancers. Herein, other than for carrying and releasing drugs, small nanoparticles were used as a potentiator of conventional chemotherapy by co-administration with free chemotherapeutic agents. This strategy avoided the problems associated with drug loading and controlled release encountered in NDDS, and was also much simpler than NDDS. Negatively charged poly(amido amine)-2,3-dimethylmaleic monoamide (PAMAM-DMA) dendrimers were prepared, which possessed low toxicity and can be converted to positively charged PAMAM dendrimers responsive to tumor acidic pH. The in situ formed PAMAM in tumor tissue promoted cellular uptake of co-administered doxorubicin by increasing the cell membrane permeability, and subsequently enhanced the cytotoxicity of doxorubicin. The small size of the dendrimers was favorable for deep penetration in tumor. Co-injection of PAMAM-DMA with doxorubicin into nude mice bearing human tumors almost completely inhibited tumor growth, with a mean tumor weight reducing by 55.9% after the treatment compared with the treatment with doxorubicin alone.


Sujet(s)
Antinéoplasiques/administration et posologie , Antinéoplasiques/composition chimique , Dendrimères/composition chimique , Animaux , Lignée cellulaire tumorale , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Préparations à action retardée/administration et posologie , Préparations à action retardée/composition chimique , Doxorubicine/administration et posologie , Doxorubicine/composition chimique , Vecteurs de médicaments/composition chimique , Systèmes de délivrance de médicaments/méthodes , Libération de médicament/effets des médicaments et des substances chimiques , Femelle , Humains , Concentration en ions d'hydrogène , Cellules MCF-7 , Souris , Souris de lignée BALB C , Souris nude , Nanoparticules/composition chimique , Polyamines/composition chimique
2.
Mater Sci Eng C Mater Biol Appl ; 59: 766-772, 2016 Feb.
Article de Anglais | MEDLINE | ID: mdl-26652431

RÉSUMÉ

Although PEG remains the gold standard for stealth functionalization in drug delivery field up to date, complete inhibition of protein corona formation on PEG-coated nanoparticles remains a challenge. To improve the stealth property of PEG, herein an α-glutamyl group was conjugated to the end of PEG and polymeric micelles with α-glutamyl-terminated PEG shells were prepared. After incubation with bovine serum albumin or in fetal calf serum, the size of the micelles changed slightly, while the size of the micelles of similar diblock copolymer but without α-glutamyl group increased markedly. These results indicated that the micelles with α-glutamyl-terminated PEG shells showed low non-specific protein adsorption. In vivo blood clearance kinetics assay showed that the micelles with α-glutamyl-terminated PEG shells exhibited a longer in vivo blood circulation time compared with similar micelles but without α-glutamyl groups. The better stealth property of the micelles with α-glutamyl-terminated PEG shells was presumably attributed to the zwitterionic property of the α-glutamyl groups.


Sujet(s)
Matériaux revêtus, biocompatibles , Nanoparticules/composition chimique , Polyéthylène glycols , Adsorption , Animaux , Bovins , Matériaux revêtus, biocompatibles/composition chimique , Matériaux revêtus, biocompatibles/pharmacocinétique , Matériaux revêtus, biocompatibles/pharmacologie , Mâle , Souris , Polyéthylène glycols/composition chimique , Polyéthylène glycols/pharmacologie , Sérumalbumine bovine/composition chimique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...